Reduction of nuclear Y654-p-β-catenin expression through SH3GL2-meditated downregulation of EGFR in chemotolerance TNBC: Clinical and prognostic importance. [electronic resource]
Producer: 20210312Description: 8114-8128 p. digitalISSN:- 1097-4652
- Adaptor Proteins, Signal Transducing -- genetics
- Adult
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- DNA Methylation -- genetics
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, erbB-1 -- genetics
- Humans
- Middle Aged
- Promoter Regions, Genetic -- drug effects
- Triple Negative Breast Neoplasms -- drug therapy
- beta Catenin -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.